Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study - April 15, 2024

Retrieved on: 2024-04-15 18:22:05

Tags for this article:

Click the tags to see associated articles and topics

Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study - April 15, 2024. View article details on hiswai:

Excerpt

Roche's (RHHBY) Columvi, in combination with GemOx, achieves the primary endpoint of overall survival in a late-stage lymphoma study.

Article found on: www.zacks.com